CHARGEPOINT HOLDINGS INC (CHPT)
US15961R1059 - Common Stock
Taking everything into account, CHPT scores 2 out of 10 in our fundamental rating. CHPT was compared to 87 industry peers in the Electrical Equipment industry. Both the profitability and financial health of CHPT have multiple concerns. CHPT is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year CHPT has reported negative net income.
In the past year CHPT has reported a negative cash flow from operations.
CHPT had negative earnings in each of the past 5 years.
In the past 5 years CHPT always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -34.43%, CHPT is not doing good in the industry: 72.09% of the companies in the same industry are doing better.
CHPT's Return On Equity of -133.68% is on the low side compared to the rest of the industry. CHPT is outperformed by 79.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.43% | ||
| ROE | -133.68% | ||
| ROIC | N/A |
ROA(3y)-53.8%
ROA(5y)-51.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CHPT's Gross Margin of 20.64% is in line compared to the rest of the industry. CHPT outperforms 52.33% of its industry peers.
CHPT's Gross Margin has declined in the last couple of years.
CHPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.78%
GM growth 5Y-13.16%
2. Health
2.1 Basic Checks
CHPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHPT has more shares outstanding
The debt/assets ratio for CHPT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -1.37, we must say that CHPT is in the distress zone and has some risk of bankruptcy.
CHPT's Altman-Z score of -1.37 is on the low side compared to the rest of the industry. CHPT is outperformed by 76.74% of its industry peers.
A Debt/Equity ratio of 1.07 is on the high side and indicates that CHPT has dependencies on debt financing.
CHPT has a Debt to Equity ratio of 1.07. This is in the lower half of the industry: CHPT underperforms 79.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.37 |
ROIC/WACCN/A
WACC10.62%
2.3 Liquidity
CHPT has a Current Ratio of 2.03. This indicates that CHPT is financially healthy and has no problem in meeting its short term obligations.
CHPT's Current ratio of 2.03 is in line compared to the rest of the industry. CHPT outperforms 45.35% of its industry peers.
A Quick Ratio of 1.61 indicates that CHPT should not have too much problems paying its short term obligations.
CHPT's Quick ratio of 1.61 is in line compared to the rest of the industry. CHPT outperforms 58.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.03 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 2.86% over the past year.
The Revenue has grown by 67.15% in the past year. This is a very strong growth!
CHPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.88% yearly.
EPS 1Y (TTM)2.86%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-33.33%
Revenue 1Y (TTM)67.15%
Revenue growth 3Y47.96%
Revenue growth 5Y49.88%
Revenue growth Q2Q38.97%
3.2 Future
Based on estimates for the next years, CHPT will show a very strong growth in Earnings Per Share. The EPS will grow by 28.91% on average per year.
CHPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.66% yearly.
EPS Next Y14.63%
EPS Next 2Y30.36%
EPS Next 3Y28.73%
EPS Next 5Y28.91%
Revenue Next Year30.07%
Revenue Next 2Y36.28%
Revenue Next 3Y35.22%
Revenue Next 5Y32.66%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CHPT. In the last year negative earnings were reported.
Also next year CHPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as CHPT's earnings are expected to grow with 28.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.36%
EPS Next 3Y28.73%
5. Dividend
5.1 Amount
CHPT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CHARGEPOINT HOLDINGS INC
NYSE:CHPT (11/30/2023, 5:33:51 PM)
After market: 1.87 +0.01 (+0.54%)1.86
-0.1 (-5.1%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)09-06 2023-09-06/amc
Earnings (Next)02-29 2024-02-29/amc
Inst Owners43.21%
Inst Owner Change-8.08%
Ins Owners19.01%
Ins Owner Change4.23%
Market Cap669.69M
Analysts81.43
Price Target10.29 (453.23%)
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.62%
Min EPS beat(2)-50.83%
Max EPS beat(2)15.58%
EPS beat(4)3
Avg EPS beat(4)1.84%
Min EPS beat(4)-50.83%
Max EPS beat(4)25.17%
Revenue beat(2)0
Avg Revenue beat(2)-2.13%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)-0.54%
Revenue beat(4)0
Avg Revenue beat(4)-5.1%
Min Revenue beat(4)-9.44%
Max Revenue beat(4)-0.54%
PT rev (1m)-5.93%
PT rev (3m)-34.54%
EPS NQ rev (1m)2.17%
EPS NQ rev (3m)-10.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.28%
Revenue NQ rev (1m)0.19%
Revenue NQ rev (3m)-14.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.2 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.43 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.95
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS1.55
BVpS0.76
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.43% | ||
| ROE | -133.68% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 20.64% | ||
| FCFM | N/A |
ROA(3y)-53.8%
ROA(5y)-51.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.78%
GM growth 5Y-13.16%
F-Score4
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 73.6% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.03 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | -1.37 |
F-Score4
WACC10.62%
ROIC/WACCN/A
Cap/Depr(3y)95.89%
Cap/Depr(5y)168.68%
Cap/Sales(3y)6.2%
Cap/Sales(5y)9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y (TTM)2.86%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-33.33%
EPS Next Y14.63%
EPS Next 2Y30.36%
EPS Next 3Y28.73%
EPS Next 5Y28.91%
Revenue 1Y (TTM)67.15%
Revenue growth 3Y47.96%
Revenue growth 5Y49.88%
Revenue growth Q2Q38.97%
Revenue Next Year30.07%
Revenue Next 2Y36.28%
Revenue Next 3Y35.22%
Revenue Next 5Y32.66%
EBIT growth 1Y-5.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.07%
EBIT Next 3Y32.24%
EBIT Next 5Y27.77%
FCF growth 1Y-195.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-214.6%
OCF growth 3YN/A
OCF growth 5YN/A